| PDF (461kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-269876
- DOI to cite this document:
- 10.5283/epub.26987
Abstract
The pharmacokinetic profile of recombinant human erythropoietin (rHuEpo) was studied after a single intravenous dose of 150 U/kg in ten patients with various degrees of renal function: group I, creatinine clearance greater than 80 ml/min, n = 2; group II, creatinine clearance 10-50 ml/min, n = 6; group III, creatinine clearance less than 3 ml/min (patients undergoing haemodialysis) n = 2. ...
Owner only: item control page